Expert Opinion on Biological Therapy

SCI期刊
Expert Opinion on Biological Therapy
中文名称:
生物治疗专家意见
期刊缩写:
Expert Opin. Biol. Ther.
影响因子:
3.6
ISSN:
print: 1471-2598
on-line: 1744-7682
研究领域:
医学-生物工程与应用微生物
创刊年份:
2001年
h-index:
75
自引率:
0.00%
Gold OA文章占比:
19.17%
原创研究文献占比:
32.98%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
Expert Opinion on Biological Therapy (1471-2598; 1744-7682) is a MEDLINE-indexed, international journal publishing peer-reviewed research across all aspects of biological therapy. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. The audience consists of scientists and managers in the healthcare and biopharmaceutical industries and others closely involved in the development and application of biological therapies for the treatment of human disease. The journal welcomes: Reviews covering therapeutic antibodies and vaccines, peptides and proteins, gene therapies and gene transfer technologies, cell-based therapies and regenerative medicine Drug evaluations reviewing the clinical data on a particular biological agent Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practice Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results; Article Highlights – an executive summary of the author’s most critical points.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
8.61.1040.876
学科
排名
百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
57 / 313
81%
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
32 / 157
79%
大类:Biochemistry, Genetics and Molecular Biology
小类:Clinical Biochemistry
26 / 117
77%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
3区 医学
2区 生物工程与应用微生物 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
3区 医学:研究与实验 MEDICINE, RESEARCH & EXPERIMENTAL
WOS期刊分区
学科分类
Q2BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Q2MEDICINE, RESEARCH & EXPERIMENTAL
历年影响因子
2015年3.4380
2016年3.6840
2017年3.9740
2018年3.5850
2019年3.2240
2020年4.3880
2021年5.5890
2022年4.6000
2023年3.6000
历年发表
2012年197
2013年173
2014年189
2015年177
2016年139
2017年158
2018年139
2019年143
2020年183
2021年139
2022年96
投稿信息
出版周期:
Bimonthly
出版语言:
English
出版国家(地区):
ENGLAND
审稿时长:
3-8 weeks
出版商:
Taylor and Francis Ltd.
编辑部地址:
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

Expert Opinion on Biological Therapy - 最新文献

Comparing anti-drug antibody signal-to-noise ratios to assess immunogenicity and interchangeability in adalimumab biosimilar studies.

Pub Date : 2024-11-19 DOI: 10.1080/14712598.2024.2428299 Lena Lemke, Andrew Blauvelt, Ines Brückmann, Hillel P Cohen, Jamie Fan, Davide Guerrieri, Matej Horvat, Johann Poetzl, Claudia Torella, Qingfeng Wang, Oliver von Richter

Endoscopic endpoints in biologic clinical trials and beyond: the case for Crohn's Disease.

Pub Date : 2024-11-18 DOI: 10.1080/14712598.2024.2430614 Marlou P M Adriaanse, Mark Löwenberg, Geert R A M D'Haens

Bispecific therapeutics: a state-of-the-art review on the combination of immune checkpoint ‎inhibition with costimulatory and non-checkpoint targeted therapy.

Pub Date : 2024-11-18 DOI: 10.1080/14712598.2024.2426636 Samin Mortaheb, Parmida Sadat Pezeshki, Nima Rezaei
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信